La Jolla Enterprise Value Trend

LJPC -- USA Stock  

Quarterly Earning Report: October 23, 2019  

This module enables investors to look at La Jolla various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Direct Expenses of 1.5 M, Cost of Revenue of 1.5 M or Interest Expense of 6.5 M, but also many exotic indicators such as PPandE Turnover of 9.1757, Accounts Payable Turnover of 1.4864 or Accrued Expenses Turnover of 1.104. This module is a perfect complement to use when analyzing La Jolla Valuation or Volatility. It can also complement various La Jolla Technical models. Please see also analysis of La Jolla Correlation with competitors.

La Jolla Enterprise Value Marginal Breakdown

Showing smoothed Enterprise Value of La Jolla Pharmaceutical Company with missing and latest data points interpolated. Enterprise Value (or EV) is usually referred to as La Jolla theoretical takeover price. In the event of an acquisition, an acquirer would have to take on La Jolla Pharmaceutical debt, but would also pocket its cash. Enterprise Value is more accurate representation of La Jolla value than its market capitalization because it takes into account all of La Jolla Pharmaceutical Company existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as [MarketCap] plus [DebtUSD] minus [CashnEqUSD].
View

335.12 M

          10 Years Trend
Increasing
Stable
 Enterprise Value 
      Timeline 

La Jolla Regression Statistics

Arithmetic Mean 44,212,234
Geometric Mean 12,295,867
Coefficient Of Variation 213.23
Mean Deviation 48,484,628
Median 42,137,140
Standard Deviation 94,274,921
Range 337,973,288
R Value 0.29
R Squared 0.08
Significance 0.37
Slope 7,512,670

La Jolla Enterprise Value Over Time

2013 (2,481,120) 
2018 (2,853,288) 
2019  335,120,000 

Other Fundumenentals of La Jolla Pharmaceutical

Search macroaxis.com